14-24210431-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014169.5(CHMP4A):āc.527A>Gā(p.Glu176Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000201 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00019 ( 0 hom., cov: 31)
Exomes š: 0.00020 ( 0 hom. )
Consequence
CHMP4A
NM_014169.5 missense
NM_014169.5 missense
Scores
1
6
11
Clinical Significance
Conservation
PhyloP100: 2.04
Genes affected
CHMP4A (HGNC:20274): (charged multivesicular body protein 4A) CHMP4A belongs to the chromatin-modifying protein/charged multivesicular body protein (CHMP) family. These proteins are components of ESCRT-III (endosomal sorting complex required for transport III), a complex involved in degradation of surface receptor proteins and formation of endocytic multivesicular bodies (MVBs). Some CHMPs have both nuclear and cytoplasmic/vesicular distributions, and one such CHMP, CHMP1A (MIM 164010), is required for both MVB formation and regulation of cell cycle progression (Tsang et al., 2006 [PubMed 16730941]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09300634).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP4A | NM_014169.5 | c.527A>G | p.Glu176Gly | missense_variant | 5/6 | ENST00000347519.12 | NP_054888.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP4A | ENST00000347519.12 | c.527A>G | p.Glu176Gly | missense_variant | 5/6 | 1 | NM_014169.5 | ENSP00000324205.11 | ||
ENSG00000254692 | ENST00000530611.1 | c.527A>G | p.Glu176Gly | missense_variant | 5/10 | 2 | ENSP00000433967.1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152096Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
29
AN:
152096
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251478Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135912
GnomAD3 exomes
AF:
AC:
38
AN:
251478
Hom.:
AF XY:
AC XY:
23
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000202 AC: 295AN: 1461878Hom.: 0 Cov.: 32 AF XY: 0.000191 AC XY: 139AN XY: 727244
GnomAD4 exome
AF:
AC:
295
AN:
1461878
Hom.:
Cov.:
32
AF XY:
AC XY:
139
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000191 AC: 29AN: 152214Hom.: 0 Cov.: 31 AF XY: 0.000228 AC XY: 17AN XY: 74416
GnomAD4 genome
AF:
AC:
29
AN:
152214
Hom.:
Cov.:
31
AF XY:
AC XY:
17
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
20
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.656A>G (p.E219G) alteration is located in exon 5 (coding exon 5) of the CHMP4A gene. This alteration results from a A to G substitution at nucleotide position 656, causing the glutamic acid (E) at amino acid position 219 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
.;.;D;T;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;.;.;M;.
MutationTaster
Benign
D;N
PrimateAI
Benign
T
PROVEAN
Benign
N;D;.;.;D
REVEL
Uncertain
Sift
Uncertain
.;D;.;.;D
Sift4G
Benign
T;D;T;T;.
Polyphen
0.0010
.;.;.;B;.
Vest4
MVP
MPC
0.042
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at